Sofinnova Investments’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,251,256
Closed -$2.79M 88
2021
Q2
$2.79M Hold
1,251,256
0.16% 58
2021
Q1
$3.19M Sell
1,251,256
-1,369,412
-52% -$5.61M 0.19% 59
2020
Q4
$17M Buy
2,620,668
+509,072
+24% +$2.31M 1.01% 23
2020
Q3
$8.55M Buy
2,111,596
+460,185
+28% +$1.73M 0.63% 27
2020
Q2
$5.98M Buy
1,651,411
+135,782
+9% +$353K 0.38% 50
2020
Q1
$2.99M Hold
1,515,629
0.28% 46
2019
Q4
$5.8M Buy
1,515,629
+77,664
+5% +$190K 0.42% 41
2019
Q3
$3.44M Buy
1,437,965
+100,397
+8% +$239K 0.31% 48
2019
Q2
$3.68M Buy
1,337,568
+313,703
+31% +$836K 0.34% 47
2019
Q1
$2.69M Hold
1,023,865
0.26% 55
2018
Q4
$1.89M Buy
1,023,865
+36,087
+4% +$85.1K 0.24% 53
2018
Q3
$2.72M Buy
987,778
+7,800
+0.8% +$25K 0.24% 49
2018
Q2
$3.77M Buy
979,978
+881,354
+894% +$3.67M 0.43% 39
2018
Q1
$414K Buy
+98,624
New +$537K 0.07% 31

Other funds holding OTIC

Sofinnova Investments's OTIC Position: Q3 2021 in Review

Sofinnova Investments sold out of Otonomy, Inc. (OTIC) in Q3 2021, closing a stake of 1,251,256 shares — an estimated $2.79M sold.

Sofinnova Investments first reported a position in OTIC in Q1 2018 and held it in 14 quarters. The position peaked at $17M in Q4 2020. 55 funds tracked by Wall St. Rank hold OTIC as of Q3 2021.

  • Sofinnova Investments reported no remaining Otonomy, Inc. position as of Q3 2021 after selling out during the quarter.
  • Sofinnova Investments sold 1,251,256 Otonomy, Inc. shares in Q3 2021, an estimated $2.79M.
  • Sofinnova Investments first reported a position in Otonomy, Inc. in Q1 2018 and held it in 14 quarters.
  • Sofinnova Investments's Otonomy, Inc. position peaked at $17M in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2021.

Based on Sofinnova Investments's 13F filing for Q3 2021, filed 15 Nov 2021.